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prevalence, patterns and correlates
Prasad Katulanda1,2*, Priyanga Ranasinghe3, Ranil Jayawardana1,4, Rezvi Sheriff1 and David R Matthews2Abstract
Metabolic Syndrome (MS) increases the risk for Coronary Artery Disease, stroke and diabetes. MS is twice more
common amongst South Asian immigrants in US compared to native Caucasians. There are no nationally
representative studies on prevalence of MS from any of the South Asian countries. The present study aims to
evaluate the prevalence of MS among Sri Lankan adults and investigates its relationships with socio-demographic,
clinical and biochemical parameters. Data on MS and its associated details were obtained from a population-based
cross-sectional study conducted between years 2005–2006. MS was defined according to the International Diabetes
Federation criteria. A binary logistic regression analysis was performed using the dichotomous variable MS
(0 = absent, 1 = present). The independent co-variants were: gender, age category, area of residence, ethnicity, level
of education, income and physical activity. Sample size was 4,485 (Response rate–89.7%), 39.5% were males and
mean age was 46.1 ± 15.1 years. The crude prevalence of MS was 27.1% (95% CI: 25.8–28.5), and age-adjusted
prevalence was 24.3% (95% CI: 23.0–25.6). Prevalence in males and females were 18.4% (95% CI: 16.5–20.3) and
28.3% (95% CI: 26.6–30.0) respectively (p< 0.001). Urban adults (34.8% [95% CI: 31.8–37.9]) had a significantly higher
prevalence than rural adults (21.6% [95% CI: 20.2–23.0]). Among ethnic groups, the highest prevalence of MS was
observed in Sri Lankan Moors (43.0% [95% CI: 37.2–48.9]). In all adults, MS was observed in those with the highest
level of education and monthly household income. Prevalence of MS in the different physical activity categories of
the IPAQ were; ‘inactive’–38.8% (95% CI 34.5-43.2), ‘moderately active’–33.5% (95% CI 30.9-36.1) and ‘active’–21.1%
(95% CI 19.6-22.7). The results of the binary logistic regression analysis indicates that female gender (OR:1.7),
increasing age, urban living (OR:1.7), Moor ethnicity (OR:2.6), secondary (OR:1.5) and tertiary levels of education
(OR:2.3), monthly household income LKR 7,000–24,999 (OR:1.5) and >50,000 (OR:2.1), and physical inactivity (OR:1.6),
all significantly increased risk of developing MS. MS is common among Sri Lankan adults affecting nearly one-fourth
of the population. Female gender, increasing age, urban living, higher socio-economical status and physical
inactivity were important associated factors.
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Metabolic Syndrome (also known as cardio-metabolic
syndrome, syndrome X and insulin resistance syndrome)
is a name given to a group of risk factors when occurring
together increases the risk for Coronary Artery Disease
(CAD), stroke, and type-2 diabetes [1,2]. These risk fac-
tors include; obesity, dysglycaemia, dyslipidaemia and* Correspondence: pkatulanda@yahoo.com
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reproduction in any medium, provided the orhypertension [3]. Insulin resistance plays a central role in
the pathophysiology of Metabolic Syndrome (MS). Evi-
dence indicates that MS begins with excess central adipos-
ity [4]. In the genetically predisposed individuals, defects
in insulin secretion follows, leading to impaired fasting
glucose (IFG) and/or impaired glucose tolerance/glucose
intolerance (IGT) [5]. Metabolic syndrome appears to have
a component of heritability, which suggests a genetic basis
[6]. Patients with rare single-gene disorders express the
clusters of metabolic abnormalities associated with MS [6].
However, the association is complex and unresolved issues
such as the role of gene-environment interactions, ethnicity,
and gender in pathogenesis need to be further explored.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion and South Asian immigrants are the fastest growing
immigrant population in many developed countries in
the world. Studies have shown higher rates of CAD, in-
sulin resistance and MS among South Asian immigrants
living in developed countries [7]. The prevalence of
CAD in South Asian immigrants was three times higher,
even after adjustment for all conventional risk factors
[8]. It is predicted that more than one-half of the world's
CAD burden will be borne by people from the Indian
subcontinent in coming decades [9]. Furthermore, evi-
dence has shown that MS is twice more common
amongst South Asian immigrants living in the US com-
pared to the native Caucasian population [10]. Several
studies have hinted at a possible genetic cause for this
high prevalence of MS in South Asians [11]. The most
recent surveys from Pakistan and India show that the
prevalence of MS is 34.8% and 25.3% respectively [12].
However these surveys are either on hospital based sam-
ples or confined only to a specific regional locality of
each country and presently there are no nationally repre-
sentative studies on the prevalence of MS from any of
the South Asian countries [12].
Sri Lanka is a middle income developing country in
South Asia with a population of over 20 million. In 2005,
the prevalence of hypertension and T2DM were nearly
20% and 11% respectively, while 1/5th of the adult popu-
lation were suffering from dysglysaemia (diabetes and
pre-diabetes) [13,14]. In addition according to South-
Asian cut-off values the prevalence of overweight (BMI≥
23 – 25.2%) and obesity (BMI ≥ 25 – 16.8%) were also at
very high levels [15]. CAD (10.6%) is the leading causes
of death in the country (by percentage of the total mor-
tality for 2000) [16]. Presently there are no published
studies on the prevalence of the metabolic syndrome in
Sri Lankan. The present study aims to evaluate the
prevalence of Metabolic Syndrome among Sri Lankan
adults and investigates the relationships between MS and
socio-demographic, clinical and biochemical parameters.Materials and methods
Study population and sampling
Data on MS and its associated details were obtained
from the Sri Lanka Diabetes and Cardiovascular Study
(SLDCS). This population-based cross-sectional study
was conducted in seven of the nine provinces in Sri
Lanka between August 2005 and September 2006. The
war affected Northern and Eastern provinces of the
country were excluded from the study. Detailed sam-
pling has been previously reported [13]. Relevant data
from the nationally representative sample of 5000 non-
institutionalized adults over 18 years of age are pre-
sented here.Measurements
Data collection was carried out by a field team of
medical graduates and nurses who were trained in re-
search methodology prior to commencement of data
collection. Details of blood sample collection and bio-
chemical analysis are described elsewhere [13]. Seated
blood pressure was recorded on two occasions after at
least a 10-min rest using an Omron IA2 digital blood
pressure monitor (Omron Healthcare, Asia-Pacific Re-
gion, Singapore). Height was measured using Harpen-
den pocket stadiometers (Chasmors Ltd, London, UK)
to the nearest 0.1 cm according to standard methods.
Body weight was measured in indoor light clothing to
the nearest 0.1 kg using a SALTER 920 digital weigh-
ing scale (Salter Ltd, Tonbridge, UK). Waist circumfer-
ence was measured at midway between iliac crest and
lower rib margin at the end of normal expiration
using a plastic flexible tape to the nearest 0.1 cm.
Similarly, the hip circumference was also measured at
the widest part of the buttocks at inter-trochantric
level to the nearest 0.1 cm. The study teams were
regularly trained and evaluated on anthropometric
measurements to minimize intra- and inter-observer
variations. Each training session concluded with a
standardization exercises, which included supervised
measurement exercises repeated as many times as ne-
cessary until no large differences were observed be-
tween measurers.
Body Mass Index (BMI) was calculated as weight in
kilograms divided by height in meters squared (kg/m2).
An interviewer administrated questionnaire was used to
obtain socio-demographic details such as age, gender,
area of residence, ethnicity, level of education and
household income. Physical activity during the past week
was assessed using, the short version of the IPAQ (Inter-
national Physical Activity Questionnaire) administered
by an interviewer. Urban and rural sectors were defined
according to the classification of the Sri Lankan govern-
ment. The study was approved by the Ethics Review
Committee of the Faculty of Medicine, University of
Colombo, Sri Lanka.
Definitions
This report is based on the definition of Metabolic Syn-
drome according to the International Diabetes Feder-
ation (IDF) criteria given below [17]:
(1) Raised Triglycerides >150 mg/l (1.7 mmol/l) or
specific treatment for hypertriglyceridaemia.
(2) Low HDL-cholesterol< 40 mg/l (1.03 mmol/l) in
males and< 50 mg/l (1.29 mmol/l) in females or
specific treatment for low HDL-cholesterol.
(3) Raised blood pressure: systolic blood
pressure> 130 mmHg or diastolic blood
Table 1 Socio-demographic characteristics in all adults,
males and females
Number of participants (%)
All Males Females
Area of residence
Urban 955 (21.3) 363 (20.5) 592 (21.8)
Rural 3,530 (78.7) 1,409 (79.5) 2,121 (78.2)
Age category
< 30 years 740 (16.5) 312 (17.6) 428 (15.8)
30-39 years 887 (19.8) 333 (18.8) 554 (20.4)
40-49 years 1,090 (24.3) 418 (23.6) 672 (24.8)
50-59 years 896 (20.0) 347 (19.6) 549 (20.2)
60-69 years 537 (12.0) 212 (12.0) 325 (12.0)
> 70 years 335 (7.5) 150 (8.5) 185 (6.8)
Ethnicity
Sinhalese 3,877 (86.4) 1,521 (85.8) 2,356 (86.8)
Tamil 299 (6.7) 134 (7.6) 165 (6.1)
Sri Lankan Moor 298 (6.6) 114 (6.4) 184 (6.8)
Level of Education
No formal education 267 (6.0) 56 (3.2) 211 (7.8)
Primary education 809 (18.0) 306 (17.4) 503 (18.5)
Secondary education 3,279 (73.1) 1,334 (75.3) 1,945 (71.7)
Tertiary education 129 (2.9) 76 (4.3) 53 (2.0)
Monthly Household Income
≤ LKR 6,999 2,504 (56.3) 862 (49.1) 1,642 (60.9)
LKR 7,000 – 24,999 1,692 (38.0) 764 (43.6) 928 (34.4)
LKR 25,000 – 49,999 207 (4.7) 104 (5.9) 103 (3.8)
≥ LKR 50,000 47 (1.1) 24 (1.4) 23 (0.9)
LKR – Sri Lankan Rupees.
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diagnosed hypertension.
(4) Dysglycaemia: fasting plasma glucose> 100 mg/l
(5.6 mmol/l) and/or 2 h post-oral glucose tolerance
test glucose >78 mmol/l or previously diagnosed
type-2 diabetes.
Those with the presence of central obesity together
with any two of the above parameters were classified as
having MS. Central obesity was classified as waist cir-
cumference> 90 cm for males and> 80 cm for females.
For the purpose of comparison with other regional and
worldwide data, the prevalence of MS is also reported
based on other commonly used diagnostic criteria pub-
lished by the; World Health Organization (WHO) and
US National Cholesterol Education Program (NCEP-
ATP III) [18,19].
Statistical analyses
All data were double-entered and cross checked for
consistency. Data were analysed using SPSS version 14
(SPSS Inc., Chicago, IL, USA) and Stata/SE 10.0 (Stata
Corporation, College Station, TX, USA) statistical soft-
ware packages. The significance of the differences be-
tween proportions (%) and means were tested using
z-test and Student’s t-test or ANOVA respectively. Direct
standardization of prevalence was performed according
to the population data published by the United Nations
population division and for the ‘WHO new world popu-
lation’ [20]. A binary logistic regression analysis was
performed using the dichotomous variable Metabolic
Syndrome (0 = absent, 1 = present). The independent co-
variants (reference category) included in the binary logis-
tic regression analysis were; gender (‘male’), age category
(‘< 30’ years), area of residence (‘rural’), ethnicity
(‘Tamil’), level of education (‘no formal education’),
monthly household income (‘<LKR7,000’) and physical
activity (‘active’). For each independent variable with
more than two categories dummy variables were created.
The first category was taken as the reference category. A
similar binary logistic regression analysis with above de-
pendant and independent variables was also performed
separately for both males and females. In all statistical
analyses P values< 0.05 were considered significant.
Results
Sample size was 4,485 (Response rate – 89.7%), 39.5%
(n = 1,772) were males. Mean age was 46.1 ± 15.1 years
(range: 18–90 years). Socio-demographic data of the
study population is summarized in Table 1. Data from
4388 subjects aged ≥20 years were used for prevalence
estimations. The crude prevalence of MS was 27.1%
(95% CI: 25.8 – 28.5), and age-adjusted prevalence was
24.3% (95% CI: 23.0 – 25.6) (IDF criteria). For thepurpose of comparison with other regional and world-
wide data, the prevalence of MS was also calculated
based World Health Organization (WHO) and US Na-
tional Cholesterol Education Program (NCEP-ATP III)
criteria [18,19]. The age-adjusted prevalence of MS
according to the WHO criteria in all adults, males and
females were 34.4% (95% CI: 33.0 – 35.8), 31.3% (95%
CI: 29.2 – 33.5) and 36.5% (95% CI: 34.7 – 38.3) respect-
ively. Females had a significantly higher prevalence than
males (p< 0.001). According to the NCEP-ATP III cri-
teria the age-adjusted prevalence of MS in all adults was
23.0% (95% CI: 21.8 – 24.3). There was a no significant
difference in prevalence between males (21.7% [95% CI:
19.8 – 23.7]) and females (23.9% [95% CI: 22.3 – 25.5]).
The remainder of the report considers MS as defined
by IDF criteria. Age-adjusted prevalence in males and
females were 18.4% (95% CI: 16.5 – 20.3) and 28.3%
(95% CI: 26.6 – 30.0) respectively, with a significantly
higher prevalence in females (p< 0.001). Most of the
subjects with MS had 4 components of the syndrome
(47.4%), 38.5% had 3, and 14.1% had all 5 components.
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triglycerides (55.1%) were the most common abnormal-
ities in all adults. A similar pattern was observed inde-
pendently in both males and females (data not shown).
Urban adults had a significantly higher prevalence of MS
than their rural counterparts and this was also observed
independently in both males and females (Table 2). The
mean age of those with MS (51.4 ± 13.2 years) was signifi-
cantly higher than those without MS (44.2± 15.3 years)
(p< 0.001). The prevalence of MS increased significantly
with increasing age in all adults, males and females
(Table 2). In the different ethnic groups, the highest
prevalence of MS was observed in Sri Lankan Moors
(Muslims), followed by Sinhalese and Tamils (Table 2).
A similar pattern was also observed in both males and
females (Table 2). The prevalence of individual compo-
nents of the MS (except low HDL cholesterol) was also
highest in Sri Lankan Moors (Additional File 1). In all
adults, the highest prevalence of MS was observed in
those with the highest level of education (‘tertiary educa-




Urban 34.8 (31.8 – 37.9) 24.3
Rural 21.6 (20.2 – 23.0) 16.6
Age category
< 30 years 7.9 (5.9 – 10.3) 6.4
30-39 years 21.4 (18.8 – 24.3) 17.4
40-49 years 29.1 (26.4 – 31.9) 19.4
50-59 years 34.3 (31.2 – 37.5) 27.7
60-69 years 38.4 (34.2 – 42.6) 28.8
> 70 years 35.5 (30.4 – 40.9) 22.0
Ethnicity
Sinhalese 23.3 (21.9 – 24.7) 17.0
Tamil 20.6 (16.2 – 25.9) 16.7
Sri Lankan Moor 43.0 (37.2 – 48.9) 35.7
Level of Education
No formal education 22.1 (17.3 – 27.7) 4.6
Primary education 18.3 (15.6 – 21.1) 10.1
Secondary education 25.8 (24.3 – 27.4) 19.5
Tertiary education 28.2 (20.4 – 36.5) 35.2
Monthly Household Income
≤ LKR 6,999 20.1 (18.5 – 21.7) 12.3
LKR 7,000 – 24,999 29.1 (26.9 – 31.3) 23.6
LKR 25,000 – 49,999 26.6 (20.7 – 33.1) 22.2
≥ LKR 50,000 30.1 (17.3 – 44.9) 27.9
* P values – Males vs. Females, BMI – Body Mass Index, NS – Not significant, LKR –This was also observed independently in males, but not
in females (Table 2). Females had a significantly higher
prevalence of MS compared to males across all; areas
of residence, age groups (except <30 years), ethnicities
(except Tamils) and levels of education (except tertiary
education) (Table 2).
Those with MS had a significantly higher weight, BMI,
waist circumference, hip circumference, waist:hip ratio,
systolic and diastolic blood pressure, fasting blood glu-
cose, 2-hr post prandial blood glucose, total and LDL
cholesterol and triglycerides (Table 3). This was
observed in both males and females independently (data
not shown). The mean weekly total MET minutes of
those with MS (3491) was significantly lower than those
without MS (5,142). A similar pattern was observed in
both males and females separately (data not shown). The
prevalence of MS in the different physical activity cat-
egories of the IPAQ was as follows; ‘inactive’ – 38.8%
(95% CI 34.5-43.2), ‘moderately active’ – 33.5% (95% CI
30.9-36.1) and ‘active’ – 21.1% (95% CI 19.6-22.7). To
evaluate the relationship between smoking and alcoholin all adults, males and females
% Confidence Interval) P value*
Males Females
(19.9 – 28.9) 40.8 (36.9 – 44.9) <0.001
(14.7 – 18.7) 24.7 (22.9 – 26.6) <0.001
(4.0 – 9.7) 7.9 (5.6 – 10.9) NS
(13.5 – 21.9) 23.8 (20.3 – 27.6) <0.05
(15.7 – 23.5) 35.1 (31.5 – 38.9) <0.001
(23.0 – 32.7) 38.4 (34.4 – 42.6) <0.01
(22.8 – 35.4) 44.6 (39.1 – 50.2) <0.001
(15.6 – 29.5) 46.5 (39.1 – 54.0) <0.001
(15.2 – 19.0) 27.2 (25.4 – 29.0) <0.001
(10.6 – 23.8) 26.4 (20.1 – 34.1) NS
(27.2 – 45.5) 45.2 (37.8 – 52.6) <0.05
(1.1 – 14.9) 26.3 (20.3 – 32.5) <0.001
(7.0 – 14.1) 24.0 (20.4 – 28.0) <0.001
(17.4 – 21.7) 30.5 (28.4 – 32.6) <0.001
(24.9 – 47.3) 15.9 (6.8 – 27.6) NS
(10.2 – 14.7) 24.3 (22.2 – 26.4) <0.001
(20.6 – 26.7) 33.7 (30.7 – 36.9) <0.001
(14.6 – 31.3) 35.8 (26.7 – 46.0) NS
(12.6 – 51.0) 28.6 (13.2 – 52.9) NS
Sri Lankan Rupees.
Table 3 Mean values of clinical and biochemical parameters in those with and without Metabolic Syndrome
Mean (±SD)
Metabolic Syndrome Non-Metabolic Syndrome p
Weight (kg) 60.5 (±11.7) 50.5 (±10.3) <0.001
Body mass index (kgm-2) 25.1 (±4.0) 20.5 (±3.6) <0.001
Waist circumference (cm) 87.4 (±9.8) 73.6 (±10.1) <0.001
Hip circumference (cm) 95.4 (±8.7) 86.6 (±8.0) <0.001
Waist:Hip ratio 0.9 (±0.1) 0.8 (±0.1) <0.001
Systolic blood pressure (mmHg) 139.2 (±18.9) 122.8 (±18.2) <0.001
Diastolic blood pressure (mmHg) 82.1 (±10.6) 72.9 (±10.5) <0.001
Fasting blood glucose (mg/dl) 105.4 (±38.6) 86.4 (±22.0) <0.001
2-hr post prandial blood glucose (mg/dl) 146.8 (±72.3) 99.7 (±37.4) <0.001
Total cholesterol (mg/dl) 220.3 (±43.0) 201.8 (±42.7) <0.001
LDL cholesterol (mg/dl) 143.6 (±38.2) 132.5 (±36.9) <0.001
HDL cholesterol (mg/dl) 42.6 (±7.8) 48.3 (±11.1) <0.001
Triglycerides (mg/dl) 169.8 (±81.9) 104.1 (±49.9) <0.001
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were only 5 current-/former- female smokers (0.2%) and
18 current-/former- female drinkers (0.6%). The age-
adjusted prevalence of MS in males who have never
smoked, former smokers and current smokers were
20.4% (95% CI: 17.5 – 23.6), 17.2% (95% CI: 13.5 – 21.4)
and 14.5% (95% CI: 11.9 – 17.4) respectively. Among the
current smokers, those who smoked 2–9 cigarettes per
day had the highest prevalence (17.3%) followed by those
smoking≤ 1 per day (13.0%) and≥ 10 per day (12.3%) re-
spectively (p-NS). In males, those who had never con-
sumed alcohol had the highest prevalence of MS (12.8%
[95% CI: 10.1 – 15.9]), followed by current drinkers
(10.3% [95% CI: 8.3 – 12.6]) and former drinkers (6.3%
[95% CI: 4.1 – 9.2]). Among current male drinkers, high-
est prevalence was found in those who drank> 21 units/
week (22.2% [95% CI: 14.5 – 31.7]), followed by those
drinking <7 units/week (19.0% [95% CI: 16.1 – 22.2])
and 7–21 units/week (18.1% [95% CI: 10.5 – 28.0]).
The results of the binary logistic regression analysis in
all adults using the dichotomous variable ‘Metabolic
Syndrome’ (0 = absent, 1 = present) as the dependant fac-
tor and other independent variables are shown in Table 4.
The overall model was statistically significant as deter-
mined by the likelihood ratio test (χ2 = 38.22, p< 0.05).
The Cox & Snell R-Square and Nagelkerke R Square
values were 0.126 and 0.184 respectively. The results in-
dicate that female gender (OR: 1.7), increasing age,
urban living (OR: 1.7), Sri Lankan Moor ethnicity (OR:
2.6), secondary (OR: 1.5) and tertiary level of education
(OR: 2.3), household income LKR 7,000 – 24,999 (OR:
1.5) and >50,000 (OR: 2.1), and physical inactivity (OR:
1.6), all were associated with significantly increased risk
of developing MS (Table 4). Similar results were seenindependently in males, however urban residency, smok-
ing and alcohol consumption were not significant risk
factors (Table 4). In females, level of education was not a
significant risk factor (Table 4).
Discussion
Metabolic Syndrome is known to increase the risks of
Coronary Artery Disease (CAD), stroke, and type-2 dia-
betes [1,2]. Recent surveys from Pakistan and India show
that the prevalence of MS is 34.8% and 25.3% respect-
ively [12]. However these surveys are either on hospital
based samples or confined only to specific regional local-
ities [21]. This is the first report on the prevalence of
MS among ethnic South Asian adults based on a com-
munity-recruited, nationally representative sample from
a South Asian country [12]. In addition, higher sample
size and response rate were the main strengths of the
study, however there was a female predominance in the
study cohort which could have been due to the fact that
the study was conducted during the day time. In most
South Asian countries females are usually housewives
while the males engage in work. We report an age-
adjusted prevalence of 24.3% in all adults (males: 18.4%,
female: 28.3%). The prevalence is similar to that of other
reports from regional South Asian countries such as;
India (Southern India – 25.8%, Northern India – 25.3%),
Pakistan (27.0%) and Nepal (22.5%) [22-24]. These stud-
ies have also used the IDF criteria for diagnosis, and they
have been conducted during a similar time period to the
present study. However, they have been confined to only
a specific locality in each country. In contrast, our preva-
lence and the prevalence in South Asian countries are
much higher than that of other regional Asian countries
such as; Singapore (17.7%), Taiwan (13.9%), Japan (7.8%)
Table 4 Binary logistic regression analysis in all adults, males and females
Odds ratio (9CI)
Co-variants (Reference category) All Male Female
Female Gender 1.7 (1.3 – 2.2)*
Age category (< 30 years)
30 – 39 years 3.8 (2.7 – 5.2)* 3.3 (1.9 – 5.8)* 3.8 (2.5 – 5.8)*
40 – 49 years 6.0 (4.4 – 8.3)* 4.2 (2.4 – 7.1)* 7.3 (4.9 – 10.9)*
50 – 59 years 8.1 (5.8 – 11.1)* 6.9 (4.0 – 11.8)* 9.5 (6.3 – 14.2)*
60 – 69 years 10.6 (7.5 – 14.9)* 9.0 (5.0 – 16.0)* 13.0 (8.4 – 20.1)*
> 70 years 8.3 (5.6 – 12.2)* 4.8 (2.5 – 9.2)* 13.2 (8.1 – 21.7)*
Urban residence 1.7 (1.4 – 2.0)* 1.1 (0.8 – 1.5) 1.8 (1.5 – 2.3)*
Ethnicity (Tamil)
Sinhalese 1.2 (0.8 – 1.6) 0.5 (0.1 – 0.7) 1.4 (0.9 – 2.1)
Sri Lankan Moor 2.6 (1.7 – 3.8)* 1.8 (0.9 – 3.5)* 3.1 (1.9 – 5.1)*
Level of education (no formal education)
Primary education 0.9 (0.7 – 1.3) 2.4 (0.8 – 7.1) 0.2 (0.02 – 2.2)
Secondary education 1.5 (1.1 – 1.9)} 3.4 (1.2 – 9.9)} 0.8 (0.6 – 1.1)
Tertiary education 2.3 (1.8 – 2.3)* 4.9 (1.5 – 16.0)# 1.1 (0.8 – 1.6)
Monthly Household Income (≤ LKR 6,999)
LKR 7,000 – 24,999 1.5 (1.3 – 1.8)* 1.7 (1.3 – 2.3)* 1.4 (1.2 – 1.8)*
LKR 25,000 – 49,999 1.2 (0.8 – 1.7) 1.2 (0.7 – 2.1) 1.2 (0.8 – 2.0)
≥ LKR 50,000 2.1 (1.1 – 4.2)* 2.2 (0.8 – 5.7) 2.2 (0.9 – 5.6)
Physical inactivity 1.6 (1.3 - 1.9)* 1.9 (1.3 – 2.7)* 1.5 (1.2 – 1.8)*
Smoking (non-smokers)
Former smokers 1.1 (0.8 – 1.5) 1.2 (0.8 – 1.7)
Current smokers 0.7 (0.5 – 0.9) 0.8 (0.6 – 1.1)
Alcohol consumption (non-consumers)
Former drinkers 0.6 (0.4 – 0.8)} 0.7 (0.4 – 1.0)
Current drinkers 0.9 (0.7 – 1.3) 0.9 (0.7 – 1.3)
* - p< 0.001, # - p< 0.01, } - p <0.05.
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(39.0%), Greece (43.4%), and western developed counties
are much higher than the prevalence in developing
South Asian countries [29,30]. However, evidence has
shown that MS is twice more common amongst South
Asian immigrants living in the US compared to the na-
tive Caucasian population [10]. Hence, it is possible to
postulate that adoption of western lifestyles after migra-
tion has led to the increased prevalence of MS amongst
immigrant South Asians.
The present study used the definition proposed by
the IDF for the purpose of defining MS. The IDF def-
inition of MS was developed in the light of the confu-
sion, ambiguity and limitation created by other
definitions. Especially amongst Asians the likely in-
appropriateness of other definitions such as the NCEP-
ATPIII has been highlighted by data showing that the
application of this definition to Asian populations
results in a very low prevalence of the metabolic syn-
drome, which is out of keeping with the highprevalence of diabetes in such populations [31]. This is
due to the inappropriateness of the NCEP-ATPIII waist
circumference cut-points for non-Europid populations.
Current evidence suggests that the WHO definition is
better able to predict those at risk of CVD than the
NCEP-ATPIII, a feature which has been attributed by
some to the central position of insulin resistance in
the WHO construct [32]. Furthermore, when insulin
resistance was added to the NCEP-ATPIII, it per-
formed similar to the WHO definition [32]. However,
measurement difficulties have limited the inclusion and
usefulness of insulin resistance in the definition.
Hence, the definition developed by the IDF consensus
group finds some compromise between the WHO and
the NCEP-ATPIII definitions, while addressing ethnic
differences between populations [33].
The reasons for the high prevalence of MS among
Sri Lankan adults are multi-factorial. As in other
South Asian countries Urbanization and mechanization
in Sri Lanka have led to a sedentary life style and
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also reported the role of genetics in the development
of obesity and MS in South Asians [12,34]. Among
South Asian immigrants in USA three novel Apo lipo-
protein A-1 single nucleotide polymorphisms were
found to be significantly associated with the presence
of MS [34]. However, further studies are required to
establish a cause-effect relationship and identify genetic
factors that are responsible. In the present study, in-
creasing age, female gender, urban residency, Sri Lan-
kan Moor ethnicity and physical inactivity were
significant risk factors associated with MS among Sri
Lankan adults. Age dependency in the prevalence of
MS is observed in most populations around the world
[35]. Our results show that prevalence of MS increased
with age, while increasing age was the strongest risk
factor associated with MS with an OR of 13.2 in
females (>70 years) and OR of 9.0 in males (60–
69 years). Substantial decline in both fertility and mor-
tality rates in Sri Lanka has led to an unprecedented
increase in the aging of its population [36]. It is esti-
mated that the geriatric population in Sri Lanka in the
coming decades would consist of a higher proportion
of females [11]. Our results show that female gender
was also a significant risk-factor and the association
between age and MS was even stronger amongst
females. The significantly higher prevalence of MS
among females could also be partly due to using a
lower WC cut-offs for defining abdominal obesity. Re-
gional studies advocate the use of same cut-off values
for both genders in South Asians [37]. Furthermore,
both age and gender are non-modifiable risk factor
and what is important is to recognize these high vul-
nerable groups and institute selective preventive mea-
sures. Urban residency was also significantly associated
with the prevalence of MS among Sri Lankan adults.
The association between MS and urban living is well-
established, especially in the developing South Asian
countries [12]. Globalization of diets and consumption
of non-traditional foods have occurred at a rapid pace
in urban areas, and alarmingly these dietary changes
are more common amongst the children and younger
adults [38,39]. The rapid increase in fast food outlets,
sale of aerated sweet drinks, and increased consump-
tion of fried snacks are common in urban areas [39].
It is also well known that South Asians are less phys-
ically active than other ethnic groups [40]. Unhealthy
dietary habits, physical inactivity and stress, all com-
bine to propagate the increasing occurrence of MS
among urban adults [41].
Higher socio-economical status as defined by educa-
tion and income were associated with increased preva-
lence of MS among Sri Lankan adults. The relationship
between educational level and MS is less distinctamongst females due to lower numbers in higher edu-
cational categories. Furthermore, although higher in-
come was associated with an increase in MS in all
adults, it is not clearly evident when genders are con-
sidered separately. This could be due to considering
household rather than individual income in the present
study. This direct association between MS and higher
social class could be due to the increased ability to pur-
chase food in those with a higher socio-economical sta-
tus. A similar trend was observed between obesity and
social class in Tunisia, a middle-income developing
country, where the increased ability to purchase food
was believed to increase the calorie intake and hence
obesity [42]. However, these findings are in contrast to
affluent countries, where obesity and MS are associated
with lower income and socio-economical status [43,44].
Among the different ethnicities Sri Lankan Moors had
a higher prevalence of MS and the Sri Lankan Moor
ethnicity was a significant risk-factor associated with
MS in the regression analysis. This could be due to dif-
ferential dietary habits and physical activity patterns
among the different ethnicities. Hence, it is important
to consider ethnic differences when instituting prevent-
ive measures.
Cigarette smoking is known to be independently
associated with metabolic syndrome, and demonstrate
a dose–response relationship [34]. The relationship
between alcohol consumption and MS is less distinct.
Some studies report a possible association between al-
cohol intake and risk of MS [45]. Other reports have
demonstrated a beneficial effect of alcohol intake on
the risk of MS, suggesting that this relationship is ra-
ther complex [46]. Alcohol consumption was reported
to have favorable effects on plasma HDL cholesterol
and insulin sensitivity, as well as unfavorable effects
of increase in plasma triglycerides and blood pressure
[47]. Our results indicate that prevalence of MS is
higher among non-smokers than smokers; however
smoking was not a significant risk-factor in the logis-
tic regression analysis. Hence the relationship between
smoking and MS is not as distinct in the present
study as previously reported [34]. However, moderate
alcohol consumption (7–21 units per week) was asso-
ciated with a lower prevalence than those consuming
higher amounts. In the present study cigarette smok-
ing and alcohol consumption were self-rated; objective
measures confirming these self-reported data, such as
measuring nicotinine in blood, urine, or saliva, could
have increased the validity of the data. However, such
measures would have not been feasible in the context
of the present study. Diet plays an important role in
the pathogenesis of MS. A whole array of dietary fac-
tors, such as unbalanced fat consumption, high so-
dium intake, low dietary fiber and unhealthy eating
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obesity, diabetes and cardiovascular disease among
South Asians [41]. Nutrition in relation to the MS
has been poorly researched among South Asians in-
cluding Sri Lankans [12]. Sri Lankans consume higher
amounts of carbohydrates, which fulfill around 70%
total daily energy intake (Unpublished data). The con-
sumption of large carbohydrate meals may cause post-
prandial hyperglycemia and hypertriglyceridaemia [41].
Presently there is a lack of data on diet and associ-
ation with MS risk factors among Sri Lankan adults
and further studies exploring this association are
required.
The value in the diagnosis of MS in an individual is
an area of much debate. Studies have shown an
increased CAD risk among subjects with 1 or 2 risk fac-
tors not falling under the MS definition, suggesting that
irrespective of the presence or absence of MS all risk
factors should be managed aggressively [48]. Among the
native Chinese population all MS criteria (IDF, WHO,
NCEP) failed to predict CAD but predicted the occur-
rence of diabetes [49]. MS criteria are known to be in-
ferior to the Framingham score for prediction of
vascular events [50]. Although MS has several limita-
tions on predicting vascular events, the concept of MS
strengthens the clinical interest and understanding of a
group of metabolic parameters among different medical
experts such as cardiology, vascular physicians, and
endocrinologist [50]. Importantly, because of the MS
concept all physicians emphasize the importance of life-
style changes, in particularly weight reduction, increase
physical activity and healthy eating. The strengths of the
present study are its’ national representativeness, ran-
dom selection of subjects out of a well-defined and
homogenous target population and the sizes of the sam-
ple population groups with a high response rate. The in-
ability to include subjects from the Northern and
Eastern provinces of the country due to the war is a
limitation of the present study. Majority of the Tamils in
Sri Lanka reside in these two provinces, while the
Tamils included in the present study were mainly plan-
tation workers of Indian origin. Furthermore the cross-
sectional design of our study limits the inference of
causality for the risk factors identified. Therefore, it is
important to conduct prospective studies on MS and
look for causality for both CAD and diabetes. In
addition although diet has a direct effect on MS we
were unable to evaluate dietary habits of Sri Lankan
adults during the present survey, due to the lack of a
validated dietary assessments tool and a nutrition com-
position database on local mixed dishes. However, cur-
rently we are in process of developing a country specific
Food Frequency Questionnaire and nutrition compos-
ition database.Conclusions
Metabolic Syndrome is common among Sri Lankan
adults affecting nearly one-fourth of the adult popula-
tion. Female gender, increasing age, urban living, higher
socio-economical status and physical inactivity were all
important factors associated with the occurrence of
Metabolic Syndrome. It is important to institute holistic,
multidisciplinary, and multi-sectoral preventive mea-
sures at an individual, community, and societal level fo-
cusing on promoting healthy dietary habits and
physically active life-styles to fight the growing epidemic
of Metabolic Syndrome in Sri Lanka.
Additional file
Additional file 1: The prevalence of individual components of
Metabolic Syndrome in different ethnicities.
Competing interests
The author(s) declare that they have no competing interests.
Acknowledgements
The National Science Foundation of Sri Lanka was the primary source of
funding for the study. The additional support provided from the Oxford
Centre for Diabetes Endocrinology and Metabolism, UK and the NIHR
Biomedical Research Centre Programme is gratefully acknowledged.
Author details
1Diabetes Research Unit, Department of Clinical Medicine, Faculty of
Medicine, University of Colombo, Colombo, Sri Lanka. 2Oxford Centre for
Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
3Department of Pharmacology, Faculty of Medicine, University of Colombo,
Colombo, Sri Lanka. 4Institute of Health and Biomedical Innovation,
Queensland University of Technology, Brisbane, Queensland, Australia.
Authors’ contributions
PK, DRM and MHRS made substantial contribution to conception and study
design. PK, PR and RJ were involved in data collection. RJ and PR were
involved in refining the study design, statistical analysis and drafting the
manuscript. RJ, PR, MHRS and PK critically revised the manuscript. All authors
read and approved the final manuscript.
Received: 15 March 2012 Accepted: 31 May 2012
Published: 31 May 2012
References
1. World Health Organization: Global recommendations on physical activity for
health. Geneva: World Health Organization; 2010.
2. World Health Organization: Global health risks: mortality and burden of
disease attributable to selected major risks. Geneva: World Health
Organization; 2009.
3. Grundy SM: Inflammation, hypertension, and the metabolic syndrome.
JAMA 2003, 290:3000–3002.
4. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR:
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before
diagnosis of type 2 diabetes: an analysis from the Whitehall II study.
Lancet 2009, 373:2215–2221.
5. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van
Pelt RE, Wang H, Eckel RH: The metabolic syndrome. Endocr Rev 2008,
29:777–822.
6. Pollex RL, Hegele RA: Genetic determinants of the metabolic syndrome.
Nat Clin Pract Cardiovasc Med 2006, 3:482–489.
7. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S: Coronary heart
disease and its risk factors in first-generation immigrant Asian Indians to
the United States of America. Indian Heart J 1996, 48:343–353.
Katulanda et al. Diabetology & Metabolic Syndrome 2012, 4:24 Page 9 of 10
http://www.dmsjournal.com/content/4/1/248. Dodani S: Coronary artery diseases in South Asian immigrants: an update
on high density lipoprotein role in disease prevention. J Immigr Minor
Health 2009, 11:415–421.
9. Dodani S: Excess coronary artery disease risk in South Asian immigrants:
can dysfunctional high-density lipoprotein explain increased risk? Vasc
Health Risk Manag 2008, 4:953–961.
10. Kuo J, Porter K: Health status of Asian Americans: United States, 1992–94.
Adv Data 1998, 7:1–16.
11. Dodani S, Henkhaus R, Wick J, Vacek J, Gupta K, Dong L, Butler MG:
Metabolic syndrome in South Asian immigrants: more than low HDL
requiring aggressive management. Lipids Health Dis 2011,
10:45.
12. Misra A, Khurana L: The metabolic syndrome in South Asians:
epidemiology, determinants, and prevention. Metab Syndr Relat Disord
2009, 7:497–514.
13. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RDA,
Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence
and projections of diabetes and pre-diabetes in adults in
Sri Lanka—Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med
2008, 25:1062–1069.
14. Wijewardene K, Mohideen MR, Mendis S, Fernando DS, Kulathilaka T,
Weerasekara D, Uluwitta P: Prevalence of hypertension, diabetes and
obesity: baseline findings of a population based survey in four provinces
in Sri Lanka. Ceylon Med J 2005, 50:62–70.
15. Katulanda P, Jayawardena MA, Sheriff MH, Constantine GR, Matthews DR:
Prevalence of overweight and obesity in Sri Lankan adults. Obes Rev
2010, 11:751–756.
16. Jayasekara R, Schultz T: Health status, trends, and issues in Sri Lanka. Nurs
Health Sci 2007, 9:228–233.
17. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide
definition. A Consensus Statement from the International Diabetes
Federation. Diabet Med 2006, 23:469–480.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults: Executive Summary of The Third Report of
The National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, And Treatment of High Blood Cholesterol
In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.
19. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, Ermini G,
Savorani G, Zocchi D, Melchionda N: WHO and ATPIII proposals for the
definition of the metabolic syndrome in patients with Type 2 diabetes.
Diabet Med 2004, 21:383–387.
20. Ahmad OB, Boschi-Pinto C, lopez AD, Murray CJL, Lozano R, Inoue M: Age
standardization of rates: A new WHO standard [GPE Discussion paper Series
No.311]. Geneva: World Health organization; 2000.
21. Misra A, Misra R, Wijesuriya M, Banerjee D: The metabolic syndrome in
South Asians: Continuing escalation & possible solutions. Indian J Med
Res 2007, 125:345–354.
22. Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic
syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the
Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res
Rev 2007, 23:127–134.
23. Basit A, Shera AS: Prevalence of metabolic syndrome in Pakistan. Metab
Syndr Relat Disord 2008, 6:171–175.
24. Sharma SK, Ghimire A, Radhakrishnan J, Thapa L, Shrestha NR, Paudel N,
Gurung K, R M, Budathoki A, Baral N, Brodie D: Prevalence of hypertension,
obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens 2011,
2011:821971.
25. Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K, Tai ES: Should central
obesity be an optional or essential component of the metabolic
syndrome? Ischemic heart disease risk in the Singapore Cardiovascular
Cohort Study. Diabetes Care 2007, 30:343–347.
26. Huang KC, Lee LT, Chen CY, Sung PK: All-cause and cardiovascular disease
mortality increased with metabolic syndrome in Taiwanese. Obesity (Silver
Spring) 2008, 16:684–689.
27. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi
H, Teramoto T, Sasaki J, Nakaya N, et al: Prevalence of metabolic syndrome
in the general Japanese population in 2000. J Atheroscler Thromb 2006,
13:202–208.
28. Villegas R, Xiang YB, Yang G, Cai Q, Fazio S, Linton MF, Elasy T, Xu WH, Li H,
Cai H, et al: Prevalence and determinants of metabolic syndromeaccording to three definitions in middle-aged Chinese men. Metab Syndr
Relat Disord 2009, 7:37–45.
29. Ford ES: Prevalence of the metabolic syndrome defined by the
International Diabetes Federation among adults in the U.S. Diabetes Care
2005, 28:2745–2749.
30. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP: The prevalence of the
metabolic syndrome using the National Cholesterol Educational Program
and International Diabetes Federation definitions. Curr Med Res Opin
2005, 21:1157–1159.
31. Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the national
cholesterol education program adult treatment panel definition
of the metabolic syndrome to Asians? Diabetes Care 2004,
27:1182–1186.
32. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto
J, Salonen JT: The metabolic syndrome and total and cardiovascular
disease mortality in middle-aged men. JAMA 2002,
288:2709–2716.
33. Magliano DJ, Shaw JE, Zimmet PZ: How to best define the metabolic
syndrome. Ann Med 2006, 38:34–41.
34. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, Jeong EK, Yoo T:
Association between cigarette smoking and metabolic syndrome: the
Korea National Health and Nutrition Examination Survey. Diabetes Care
2005, 28:2064–2066.
35. AlSaraj F, McDermott JH, Cawood T, McAteer S, Ali M, Tormey W, Cockburn
BN, Sreenan S: Prevalence of the metabolic syndrome in patients with
diabetes mellitus. Ir J Med Sci 2009, 178:309–313.
36. Perera B: Social support and social security issues of elders in Sri Lanka.
Galle Medical Journal 2011, 16:20–23.
37. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR,
Sadikot S, Gupta R, Gulati S, Munjal YP: Consensus statement for diagnosis
of obesity, abdominal obesity and the metabolic syndrome for Asian
Indians and recommendations for physical activity, medical and surgical
management. J Assoc Physicians India 2009, 57:163–170.
38. Wasir JS, Misra A: The metabolic syndrome in asian indians: impact of
nutritional and socio-economic transition in India. Metab Syndr Relat
Disord 2004, 2:14–23.
39. Misra A, Khurana L, Vikram NK, Goel A, Wasir JS: Metabolic syndrome in
children: current issues and South Asian perspective. Nutrition 2007,
23:895–910.
40. Kanjilal S, Rao VS, Mukherjee M, Natesha BK, Renuka KS, Sibi K, Iyengar SS,
Kakkar VV: Application of cardiovascular disease risk prediction models
and the relevance of novel biomarkers to risk stratification in Asian
Indians. Vasc Health Risk Manag 2008, 4:199–211.
41. Misra A, Khurana L, Isharwal S, Bhardwaj S: South Asian diets and insulin
resistance. Br J Nutr 2009, 101:465–473.
42. Beltaifa L, Traissac P, El Ati J, Lefevre P, Romdhane HB, Delpeuch F:
Prevalence of obesity and associated socioeconomic factors among
Tunisian women from different living environments. Obes Rev 2009,
10:145–153.
43. Matthews KA, Raikkonen K, Gallo L, Kuller LH: Association between
socioeconomic status and metabolic syndrome in women: testing the
reserve capacity model. Health Psychol 2008, 27:576–583.
44. Santos AC, Ebrahim S, Barros H: Gender, socio-economic status and
metabolic syndrome in middle-aged and old adults. BMC Public Health
2008, 8:62.
45. Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, Trevisan
M: Lifetime alcohol drinking pattern is related to the prevalence of
metabolic syndrome. The Western New York Health Study (WNYHS). Eur
J Epidemiol 2006, 21:129–138.
46. Djousse L, Arnett DK, Eckfeldt JH, Province MA, Singer MR, Ellison RC:
Alcohol consumption and metabolic syndrome: does the type of
beverage matter? Obes Res 2004, 12:1375–1385.
47. Linn S, Carroll M, Johnson C, Fulwood R, Kalsbeek W, Briefel R: High-density
lipoprotein cholesterol and alcohol consumption in US white and black
adults: data from NHANES II. Am J Public Health 1993,
83:811–816.
48. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F:
Prevalence of metabolic syndrome by the Adult Treatment Panel III,
International Diabetes Federation, and World Health Organization
definitions and their association with coronary heart disease in an
Katulanda et al. Diabetology & Metabolic Syndrome 2012, 4:24 Page 10 of 10
http://www.dmsjournal.com/content/4/1/24elderly Iranian population. Ann Acad Med Singapore 2009,
38:142–149.
49. Wang JJ, Li HB, Kinnunen L, Hu G, Jarvinen TM, Miettinen ME, Yuan S,
Tuomilehto J: How well does the metabolic syndrome defined by five
definitions predict incident diabetes and incident coronary heart
disease in a Chinese population? Atherosclerosis 2007, 192:161–168.
50. Sattar N: Why metabolic syndrome criteria have not made prime time: a
view from the clinic. Int J Obes (Lond) 2008, 32(Suppl 2):S30–34.
doi:10.1186/1758-5996-4-24
Cite this article as: Katulanda et al.: Metabolic syndrome among Sri
Lankan adults: prevalence, patterns and correlates. Diabetology &
Metabolic Syndrome 2012 4:24.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
